Preprint Case Report Version 1 Preserved in Portico This version is not peer-reviewed

Brimonidine Eye Drops at the Children Reach: A Possible Foe

Version 1 : Received: 30 January 2024 / Approved: 30 January 2024 / Online: 30 January 2024 (12:44:49 CET)

A peer-reviewed article of this Preprint also exists.

Trotta, D.; Zucchelli, M.; Salladini, C.; Ballerini, P.; Rossi, C.; Aricò, M. Brimonidine Eye Drops within the Reach of Children: A Possible Foe. Children 2024, 11, 317. Trotta, D.; Zucchelli, M.; Salladini, C.; Ballerini, P.; Rossi, C.; Aricò, M. Brimonidine Eye Drops within the Reach of Children: A Possible Foe. Children 2024, 11, 317.

Abstract

Brimonidine, a selective alpha-2 adrenergic agonist, used for treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one case of transient encephalopathy in a toddler, in whom brimonidine accidental toxicity was sus-pected and then confirmed by a toxicology study. The 8-month-old healthy girl child was taken to the pediatric ER since she was drowsy and hypotonic, with miosis. Brain CT scan and toxicological work-up on blood and urine were negative. Starting from hour +4, the child progressively improved, and by hour +6, she recovered to a normal state of consciousness. A survey of available drugs at the child’s reach showed the presence of brimonidine. Thus, ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) was applied to quantify brimonidine in urine and plasma samples, showing 8.40 ng/mL level and 0.79 ng/mL, respectively. To our knowledge, this is the first report for determining brimonidine levels in urine and plasma by UPLC-MS/MS. Insufficient knowledge of the family members about the potential hazards of an apparently innocuous, topical medication such as eye drops may put children at a greater risk of poisoning. Necessary warnings should be better given to parents when prescribing this medication.

Keywords

Brimonidine, eye-drop poisoning, tandem mass spectrometry

Subject

Medicine and Pharmacology, Pediatrics, Perinatology and Child Health

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.